Xiang Haibo, Ding Pengbing, Qian Jiaying, Lu Enhang, Sun Yimou, Lee Seyeon, Zhao Zhenkun, Sun Zhixuan, Zhao Zhenmin
Department of Plastic Surgery, Peking University Third Hospital, No. 49 North Garden Road, Haidian District, Beijing, 100191, China.
Department of Plastic and Reconstructive Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Stem Cell Res Ther. 2024 Dec 3;15(1):462. doi: 10.1186/s13287-024-04069-5.
Minor salivary gland mesenchymal stem cells (MSGMSCs) can be easily extracted and have a broad range of sources. Applying exosomes to wounds is a highly promising method for promoting wound healing. Exosomes derived from different stem cell types have been proven to enhance wound healing, with adipose-derived stem cell (ADSC)-derived exosomes being the most extensively researched. Considering that MSGMSCs have advantages such as easier extraction compared to ADSCs, MSGMSCs should also be a very promising type of stem cell in exosome therapy. However, whether MSGMSC-derived exosomes (MSGMSC-exos) can promote wound healing and how they compare to ADSC-derived exosomes (ADSC-exos) in the wound healing process remain unclear.
The effects of MSGMSC-exos and ADSC-exos on angiogenesis in wound healing were investigated in vitro using CCK-8, scratch assays, and tube formation assays. Subsequently, the promotion of wound healing by MSGMSC-exos and ADSC-exos was evaluated in vivo using a full-thickness wound defect model in mice. Immunohistochemistry was used to verify the effects of MSGMSC-exos and ADSC-exos on promoting collagen deposition, angiogenesis, and cell proliferation in the wound. Immunofluorescence staining was performed to investigate the role of MSGMSC-exos and ADSC-exos in modulating the inflammatory response in the wound. Furthermore, proteomic sequencing was conducted to investigate the functional similarities and differences between the proteomes of MSGMSC-exos and ADSC-exos, with key protein contents verified by ELISA.
MSGMSC-exos exhibited similar effects as ADSC-exos in promoting the migration, proliferation, and tube formation of human umbilical vein endothelial cells (HUVECs) in vitro, with a comparable dose-dependent effect. In vivo experiments confirmed that MSGMSC-exos have similar wound healing-promoting functions as ADSC-exos. MSGMSC-exos promoted the neovascularization and maturation of blood vessels in vivo at a level comparable to ADSC-exos. Despite MSGMSC-exos showing less collagen deposition than ADSC-exos, they exhibited stronger anti-scar formation and anti-inflammatory effects. Proteomic analysis revealed that the proteins promoting wound healing in both MSGMSC-exos and ADSC-exos were relatively conserved, with ITGB1 identified as a critical protein for angiogenesis. Further differential analysis revealed that the functions specifically enriched in MSGMSC-exos and ADSC-exos reflected the functions of their source tissue.
Our study confirms that MSGMSC-exos exhibit highly similar wound healing and angiogenesis-promoting functions compared to ADSC-exos, and the proteins involved in promoting wound healing in both are relatively conserved. Moreover, MSGMSC-exos show stronger anti-scar formation and anti-inflammatory effects than ADSC-exos. This suggests that MSGMSCs are a promising stem cell source with broad applications in wound healing treatment.
小唾液腺间充质干细胞(MSGMSCs)易于提取且来源广泛。将外泌体应用于伤口是促进伤口愈合的一种极具前景的方法。已证实源自不同干细胞类型的外泌体可促进伤口愈合,其中脂肪来源干细胞(ADSC)衍生的外泌体研究最为广泛。鉴于与ADSCs相比,MSGMSCs具有更容易提取等优势,在伤口愈合治疗中,MSGMSCs在外泌体疗法中也应是一种非常有前景的干细胞类型。然而,MSGMSC衍生的外泌体(MSGMSC-exos)是否能促进伤口愈合,以及它们在伤口愈合过程中与ADSC衍生的外泌体(ADSC-exos)相比情况如何,仍不清楚。
使用CCK-8、划痕实验和管腔形成实验在体外研究了MSGMSC-exos和ADSC-exos对伤口愈合中血管生成的影响。随后,使用小鼠全层伤口缺损模型在体内评估了MSGMSC-exos和ADSC-exos对伤口愈合的促进作用。采用免疫组织化学法验证了MSGMSC-exos和ADSC-exos对促进伤口胶原沉积、血管生成和细胞增殖的作用。进行免疫荧光染色以研究MSGMSC-exos和ADSC-exos在调节伤口炎症反应中的作用。此外,进行了蛋白质组测序,以研究MSGMSC-exos和ADSC-exos蛋白质组之间的功能异同,并通过ELISA验证关键蛋白质含量。
在体外,MSGMSC-exos在促进人脐静脉内皮细胞(HUVECs)迁移、增殖和管腔形成方面表现出与ADSC-exos相似的作用,且具有类似的剂量依赖性效应。体内实验证实,MSGMSC-exos与ADSC-exos具有相似的促进伤口愈合功能。MSGMSC-exos在体内促进血管新生和血管成熟的程度与ADSC-exos相当。尽管MSGMSC-exos显示出比ADSC-exos更少的胶原沉积,但它们表现出更强的抗瘢痕形成和抗炎作用。蛋白质组分析表明,MSGMSC-exos和ADSC-exos中促进伤口愈合的蛋白质相对保守,ITGB1被确定为血管生成的关键蛋白。进一步的差异分析表明,MSGMSC-exos和ADSC-exos中特异性富集的功能反映了其来源组织的功能。
我们的研究证实,与ADSC-exos相比,MSGMSC-exos在促进伤口愈合和血管生成方面表现出高度相似的功能,且两者中参与促进伤口愈合的蛋白质相对保守。此外,MSGMSC-exos比ADSC-exos表现出更强的抗瘢痕形成和抗炎作用。这表明MSGMSCs是一种有前景的干细胞来源,在伤口愈合治疗中具有广泛应用。